Method for quantification of opioids and their metabolites in autopsy blood by liquid chromatography-tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 31, Issue 7, 2007, Pages 394-408

  Al Asmari, Ahmed I ^a   Anderson, Robert A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 ACETYLCODEINE; ACETONITRILE; AMMONIUM FORMATE; BENZOYLECGONINE; BUPRENORPHINE; BUPRENORPHINE 3 GLUCURONIDE; CODEINE; CODEINE 6 GLUCURONIDE; DIAMORPHINE; DIAZEPAM; DIHYDROCODEINE; DIHYDROCODEINE 6 GLUCURONIDE; DIHYDROMORPHINE; DIHYDROMORPHINE 3 GLUCURONIDE; DIHYDROMORPHINE 6 GLUCURONIDE; HYDROMORPHONE; METHADONE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 ACETATE; MORPHINE 6 GLUCURONIDE; NALOXONE; NALOXONE 3 GLUCURONIDE; NORBUPRENORPHINE; NORBUPRENORPHINE 3 GLUCURONIDE; NORCODEINE; NORMORPHINE; OPIATE DERIVATIVE; OXYCODONE; OXYMORPHONE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; BLOOD ANALYSIS; CADAVER; CHROMATOGRAPHY; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG MEGADOSE; DRUG OVERDOSE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; RESPIRATION DEPRESSION; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; UNSPECIFIED SIDE EFFECT;

EID: 34548848537     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.7.394     Document Type: Article

References (58)

1. O.H. Drummer and M. Odell. Forensic Pharmacology Drugs of Abuse, 1st ed. Hodder Arnold, London, U.K., 2001.
2. B. Levine. Principles of Forensic Toxicology. Association for Clinical Chemistry, Washington, D.C., 1998.
3. United Nations Office on Drugs and Crime, World Drug Report, 2006, http://www.unodcorg/unodc/en/world_drug_report.html, May 2006.
4. R. Kaushik, B. Levine, and W.R. LaCourse. A brief review: HPLC methods to directly detect drug glucuronides in biological matrices (Part I). Anal. Chim. Acta 556: 255-266 (2006).
5. P.A. Glare, T.D. Walsh, and C.E. Pippenger. A simple, rapid method for the simultaneous determination of morphine and its principal metabolites in plasma using high-performance liquid chromatography and fluorometric detection. Ther. Drug Monit. 13: 226-232 (1991).
6. J.L. Mason, S.P. Ashmore, and A.R. Aitkenhead. Simple method for the determination of morphine and its active glucuronide metabolite in human plasma by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B 570: 191-197 (1991).
7. Y. Rotshteyn and B. Weingarten. A highly sensitive assay for the simultaneous determination of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma by high-performance liquid chromatography with electrochemical and fluorescence detection. Ther. Drug Monit. 18: 179-188 (1996).
8. J.O. Svensson. Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high-performance liquid-chromatography and electrochemical detection. J. Chromatogr. 375: 174-178 (1986).
9. J.O. Svensson, A. Rane, J. Sawe, and F. Sjoqvist. Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine usin ion-pair high-performance liquid chromatography. J. Chromatogr. 230: 427-432 (1982).
10. H. Hoja, P. Marquet, B. Verneuil, H. Lotfi, B. Penicaut, and G. Lachatre. Applications of liquid chromatography-mass spectrometry in analytical toxicology: a review. J. Anal. Toxicol. 21: 116-126 (1997).
11. M.C. McMaster. LC/MS: A Practical User's Guide. Wiley, Hoboken, NJ, 2005.
12. M. Wood, M. Laloup, M. del Ramirez Fernandez, K.M. Jenkins, M.S. Young, J.G. Ramaekers, G. De Boeck, and N. Samyn. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci. Int. 150: 227-238 (2005).
13. K.R. Allen, R. Azad, H.P. Field, and D.K. Blake. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid. Ann. Clin. Biochem. 42: 277-284 (2005).
14. M.J. Bogusz. Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity. J. Chromatogr. B 748: 3-19 (2000).
15. F.M. Wylie, H. Torrance, R.A. Anderson, and J.S. Oliver. Drugs in oral fluid part 1. Validation of an analytical procedure for licit and illicit drugs in oral fluid. Forensic Sci. Int. 150: 191-198 (2005).
16. J.N. Miller and J.C. Miller. Statistics and Chemometrics for Analytical Chemistry, 4th ed. Prentice Hall, New York, NY, 2000.
17. B.K. Matuszewski, M.L. Constanzer, and C.M. Chavez-Eng. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75: 3019-3030 (2003).
18. C.M. Murphy and M.A. Huestis. LC-ESI-MS/MS analysis for the quantification of morphine, codeine, morphine-3-beta-D-glucuronide, morphine-6-beta-D-glucuronide, and codeine-6-beta-D-glucuronide in human urine. J. Mass Spectrom. 40: 1412-1416 (2005).
19. A. Dienes-Nagy, L. Rivier, C. Giroud, M. Augsburger, and P. Mangin. Method for quantification of morphine and its 3-and 6-glucuronides, codeine, codeine glucuronide and 6-monoacetylmorphine in human blood by liquid chromatography-electrospray mass spectrometry for routine analysis in forensic toxicology. J. Chromatogr. A 854: 109-118 (1999).
20. H.J. Leis, G. Fauler, G. Raspotnig, and W. Windischhofer. Quantitative gas chromatographic/mass spectrometric analysis of morphine glucuronides in human plasma by negative ion chemical ionization mass spectrometry. J. Mass Spectrom. 37: 395-400 (2002).
21. D. Moody, J. Laycock, A. Spanbauer, D. Crouch, R. Foltz, J. Josephs, L. Amass, and W. Bickel. Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 21: 406-414 (1997).
22. M.J. Bogusz, R.D. Maier, K.D. Kruger, and U. Kohls. Determination of common drugs of abuse in body fluids using one isolation procedure and liquid chromatography-atmospheric-pressure chemical-ionization mass spectromery. J. Anal. Toxicol. 22: 549-558 (1998).
23. M. Dawson, B. Fryirs, T. Kelly, J Keegan, and L.E. Mather. A rapid and sensitive high-performance liquid chromatography-electrospray ionization-triple quadrupole mass spectrometry method for the quantitation of oxycodone in human plasma. J. Chromatogr. Sci. 40: 40-44 (2002).
24. K. Klinder, G. Skopp, R. Mattern, and R. Aderjan. The detection of dihydrocodeine and its main metabolites in cases of fatal overdose. Int. J. Legal Med. 112: 155-158 (1999).
25. E.J. Rook, M.J. Hillebrand, H. Rosing, J.M. van Ree, and J.H. Beijnen. The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. B 824: 213-221 (2005).
26. E.I. Miller, H.J. Torrance, and J.S. Oliver. Validation of the Immunalysis microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine. J. Anal. Toxicol. 30: 115-119 (2006).
27. M.M. Ariffin and R.A. Anderson. LC/MS/MS analysis of quaternary ammonium drugs and herbicides in whole blood. J. Chromatogr. B 842: 91-97 (2006).
28. E.I. Miller, F.M. Wylie, and J.S. Oliver. Detection of Benzodiazepines in hair using ELISA and LC-ESI-MS-MS. J. Anal. Toxicol. 30: 441-448 (2006).
29. K.B. Scheidweiler and M.A. Huestis. Simultaneous quantification of opiates, cocaine, and metabolites in hair by LC-APCI-MS/MS. Anal. Chem. 76: 4358-4363 (2004).
30. D. Dadgar and P.E. Burnett. Issues in evaluation of bioanalytical method selectivity and drug stability. J. Pharm. Biomed. Anal. 14: 23-31 (1995).
31. F.T. Peters, O.H. Drummer, and F. Musshoff. Validation of new methods. Forensic Sci. Int. 165: 216-224 (2007).
32. O.H. Drummer. Postmortem toxicology of drugs of abuse. Forensic Sci. Int. 142: 101-113 (2004).
33. W.Z. Shou, M. Pelzer, T. Addison, X. Jiang, and W. Naidong. An automatic 96-well solid phase extraction and liquid chromatography-tandem mass spectrometry method for the analysis of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human plasma. J. Pharm. Biomed. Anal. 27: 143-152 (2002).
34. D. Whittington and E.D. Kharasch. Determination of morphine and morphine glucuronides in human plasma by 96-well plate solid-phase extraction and liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B 796: 95-103 (2003).
35. G. Skopp, L. Potsch, A. Klingmann, and R. Mattern. Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and post-mortem blood sample. J. Anal. Toxicol. 25: 2-7 (2001).
36. W. Huang, D. Moody, and E. McCance-Katz. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography- electrospray ionization-tandem mass spectrometry. Ther. Drug Monit. 28(2): 245-251 (2006).
37. C.M. Murphy and M.A. Huestis. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-beta-D-glucuronide and norbuprenorphine-3-beta-D-glucuronide in human plasma. J. Mass Spectrom. 40: 70-74 (2005).
38. W. Naidong, X. Jiang, K. Newland, R. Coe, P. Lin, and J. Lee. Development and validation of a sensitive method for hydromorphone in human plasma by normal phase liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 23: 697-704 (2000).
39. B. Weingarten, H.Y. Wang, and D.M. Roberts. Determination of codeine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. A 696: 83-92 (1995).
40. G. Ceder and A.W. Jones. Concentration ratios of morphine to codeine in blood of impaired drivers as evidence of heroin use and not medication with codeine. Clin. Chem. 47: 1980-1984 (2001).
41. F. Moriya, K.M. Chan, and Y. Hashimoto. Concentrations of morphine and codeine in urine of heroin abusers. Legal Med. (Tokyo) 1: 140-144 (1999).
42. M.J. Burt, J. Kloss, and F.S. Apple. Postmortem blood free and total morphine concentrations in medical examiner cases. J. Forensic Sci. 46: 1138-1142 (2001).
43. J. Gerostamoulos and O.H. Drummer. Postmortem redistrubtion of morphine and its metabolites. J. Forensic Sci. 45: 843-845 (2001).
44. M.J. Bogusz, R.-D. Maier, M. Erkens, and S. Driessen. Determination of morphine and its 3- and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry. J. Chromatogr. B 703: 115-127 (1997).
45. R. Aderjan, S. Hofmann, G. Schmitt, and G. Skopp. Morphine and morphine glucuronides in serum of heroin consumers and heroin-related deaths determined by HPLC with native fluorescence detection. J. Anal. Toxicol. 19: 163-168 (1995).
46. C. Staub, R. Jeanmonod, and O. Frye. Morphine in post-mortem blood: its importance for the diagnosis of deaths associated with opiate additicition. Int. J. Legal Med. 104: 39-42 (1990).
47. V. Spiehler and R. Brown. Unconjugated morphine in blood by radioimmunoassay and gas chromatography/mass spectrometry. J. Forensic Sci. 32(4): 906-916 (1987).
48. J.C. Garriott and W.Q. Sturner. Morphine concentrations and survival periods in acute heroin fatalities. N. Engl. J. Med. 289: 1276-1278 (1973).
49. B. Levine, D. Green, and J.E. Smialek. The role of ethanol in heroin deaths. J. Forensic Sci. 40(5): 808-810 (1995).
50. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 7th ed. Biomedical Publications, Foster City, CA, 2004.
51. J. Findlay, R. Jones, R. Buutz, and R. Welch. Plasma codeine and morphine concentrations after therapeutic oral dose of codeine-containing analgesics. Clin. Pharm. Ther. 24: 60-68 (1978).
52. M.A. Peat and A. Sengupta. Toxicology investigations of cases of death involving codeine and dihydrocodeine. Forensic Sci. Int. 9: 21-23 (1977).
53. G. Skopp, K. Klinder, L. Potsch, G. Zimmer, R. Lutz, R. Aderjan, and R. Mattern. Postmortem distribution of dihydrocodeine and metabolites in a fatal case of dihydrocodeine intoxication. Forensic Sci. Int. 95: 99-107 (1998).
54. S. Darke. Polydrug use and overdose: overthrowing old myths. Addiction 98: 711 (2003).
55. S. Darke, S. Sunjic, D. Zedor, and T. Prolov. A comparision of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia. Drug Alcohol Depend. 47: 45-53 (1997).
56. A. Ruttenber, H. Kalter, and P. Santinga. The role of ethanol abuse in the etiology of heroin-related death. J. Forensic Sci. 35(4): 891-900 (1990).
57. A. Polettini, A. Groppi, and M. Montagna. The role of alcohol abuse in the etiology of heroin-related death. Evidence for pharmacokinetic interactions between heroin and alcohol. J. Anal. Toxicol. 23: 570-576 (1999).
58. A. Polettini, V. Poloni, A. Groppi, C. Stramesi, C. Vignali, L. Politi, and M. Montagna. The role of cocaine in heroin-related deaths hypothesis on the interaction between heroin and cocaine. Forensic Sci. Int. 153: 23-28 (2005).